Successful response to rituximab in a patient with pure red cell aplasia complicating chronic lymphocytic leukaemia (Q74674068)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12199808%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Successful response to rituximab in a patient with pure red cell aplasia complicating chronic lymphocytic leukaemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12199808%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12199808%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

Montserrat Batlle

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12199808%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Josep-Maria Ribera

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12199808%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Esther Plensa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12199808%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Fuensanta Millá

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12199808%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Evarist Feliu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12199808%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

English

0 references

publication date

1 September 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12199808%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Haematology

12 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12199808%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12199808%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12199808%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

1192-1193

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12199808%20AND%20SRC:MED&resulttype=core&format=json

Treatment of refractory autoimmune haemolytic anaemia with anti-CD20 (rituximab)

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.36892.X

Rituximab: a very efficient therapy in cold agglutinins and refractory autoimmune haemolytic anaemia associated with CD20-positive, low-grade non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.36892.X

Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.36892.X

Sustained remission of platelet counts following monoclonal anti-CD20 antibody therapy in two cases of idiopathic autoimmune thrombocytopenia and neutropenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.36892.X

Rituximab in a case of cold agglutinin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.36892.X

Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.36892.X

10.1046/J.1365-2141.2002.36892.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12199808%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference